Scarica l'app Stockscreener
13.77
6.21%
0.805
Dopo l'orario di chiusura:
13.77
0.005
+0.04%
Precedente Chiudi:
$12.96
Aprire:
$12.87
Volume 24 ore:
27,384
Relative Volume:
0.99
Capitalizzazione di mercato:
$66.58M
Reddito:
$2.61M
Utile/perdita netta:
$1.69M
Rapporto P/E:
45.84
EPS:
0.3003
Flusso di cassa netto:
-
1 W Prestazione:
+13.28%
1M Prestazione:
+25.14%
6M Prestazione:
+69.52%
1 anno Prestazione:
+59.13%
Intervallo 1D:
$12.19
$14.00
Intervallo di 1 settimana:
$11.70
$14.00
Portata 52W:
$6.55
$14.00
Daxor Corporation Stock (DXR) Company Profile
Nome
Daxor Corporation
Settore
Industria
Telefono
212-330-8500
Indirizzo
Empire State Building, Suite 7120 350 Fifth Avenue, New York, NY
Confronta DXR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DXR
Daxor Corporation
|
13.77 | 64.60M | 2.61M | 1.69M | 0 | 0.3003 |
|
ISRG
Intuitive Surgical Inc
|
447.23 | 157.45B | 9.15B | 2.63B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
187.17 | 52.74B | 21.39B | 1.61B | 2.55B | 5.56 |
|
RMD
Resmed Inc
|
273.73 | 39.69B | 5.15B | 1.40B | 1.65B | 9.51 |
|
ALC
Alcon Inc
|
74.51 | 36.64B | 10.03B | 1.07B | 1.39B | 2.17 |
|
WST
West Pharmaceutical Services Inc
|
262.33 | 18.72B | 2.96B | 487.70M | 344.00M | 6.68 |
Daxor Corporation Stock (DXR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2019-05-16 | Iniziato | Ascendiant Capital Markets | Buy |
Daxor Corporation Borsa (DXR) Ultime notizie
How to manage a losing position in Daxor CorporationOptions Play & Real-Time Market Sentiment Alerts - newser.com
Daxor Corporation's BVA Technology Proven to Reduce Hospital Readmissions and Enhance Survival Rates in Heart Failure Patients - Quiver Quantitative
Daxor Unveils New FDA-Cleared BVA Analyzer Amid Strong Market Demand and Pivotal Clinical Data at HFSA - GlobeNewswire
Zero Hospital Readmissions: Daxor's New Blood Volume Tech Shows Perfect Results in Heart Failure Study - Stock Titan
Technical analysis overview for Daxor Corporation stock2025 Performance Recap & Detailed Earnings Play Strategies - newser.com
Can Daxor Corporation (DX5) stock retain market dominanceJuly 2025 Trade Ideas & Verified Short-Term Trading Plans - newser.com
What technical patterns form on Daxor Corporation (DX5) stock chartsEarnings Risk Summary & Real-Time Volume Spike Alerts - newser.com
Why Daxor Corporation (DX5) stock could rally stronglyEarnings Growth Report & Stepwise Entry/Exit Trade Alerts - newser.com
Daxor (NASDAQ:DXR) Trading 7.6% Higher – What’s Next? - Defense World
Comparing Daxor (NASDAQ:DXR) & LifeStance Health Group (NASDAQ:LFST) - Defense World
Can Daxor Corporation recover in the next quarter2025 Investor Takeaways & Weekly Top Gainers Alerts - newser.com
Can Oswal Agro Mills Limited Deliver Growth Even in a Bearish MarketMarket Sentiment Shifts & Low Risk Trading Alerts - earlytimes.in
Is Daxor Corporation meeting your algorithmic filter criteriaM&A Rumor & Consistent Growth Stock Picks - newser.com
What drives Daxor Corporation stock priceTechnology Stock Trends & Follow Top Performers in the Community - earlytimes.in
What analysts say about Daxor Corporation stockPrice Action Analysis & Double Or Triple Wealth - earlytimes.in
Historical volatility pattern of Daxor Corporation visualizedJuly 2025 PostEarnings & Real-Time Chart Breakout Alerts - newser.com
Will Daxor Corporation stock rally after Fed decisionsEarnings Summary Report & Community Trade Idea Sharing - newser.com
Published on: 2025-09-26 14:13:58 - newser.com
Daxor to showcase new FDA-cleared blood volume analyzer at HFSA meeting - Investing.com Nigeria
Daxor to showcase new FDA-cleared blood volume analyzer at HFSA meeting By Investing.com - Investing.com South Africa
Daxor unveils next-gen BVA analyzer at HFSA annual meeting - TipRanks
Daxor (DXR) Showcases Next-Gen Blood Volume Analyzer at Key Medi - GuruFocus
Daxor Corporation to Showcase Next-Generation Blood Volume Analyzer at HFSA Annual Scientific Meeting, Highlighting New Clinical Data for Improved Heart Failure Management - Quiver Quantitative
Daxor Corporation Unveils Breakthrough Next-Gen BVA Analyzer at HFSA Annual Scientific Meeting - GlobeNewswire
3X Faster Blood Testing: Daxor's Revolutionary FDA-Cleared Heart Failure Analyzer Changes Patient Care - Stock Titan
Daxor Corporation stock momentum explainedTrade Risk Report & Target Return Focused Stock Picks - newser.com
The Pennant Group (NASDAQ:PNTG) vs. Daxor (NASDAQ:DXR) Head to Head Analysis - Defense World
Daxor Corporation (NASDAQ:DXR) Short Interest Update - MarketBeat
Tools to assess Daxor Corporation’s risk profile2025 Technical Overview & Verified Trade Idea Suggestions - newser.com
Quantitative breakdown of Daxor Corporation recent moveCPI Data & Weekly Setup with High ROI Potential - newser.com
Update Recap: What is the target price for Daxor Corporation stock2025 Dividend Review & Free Reliable Trade Execution Plans - خودرو بانک
Daxor Corporation Azioni (DXR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.91%
1.74%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):